# Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis

> **NCT04411316** · PHASE4 · WITHDRAWN · sponsor: **University of Toledo Health Science Campus**

## Conditions studied

- Deep Venous Thrombosis
- Post Thrombotic Syndrome

## Interventions

- **COMBINATION_PRODUCT:** Catheter directed thrombolysis plus anticoagulation
- **DRUG:** Anticoagulation

## Key facts

- **NCT ID:** NCT04411316
- **Lead sponsor:** University of Toledo Health Science Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-12-19
- **Primary completion:** 2022-12-19
- **Final completion:** 2022-12-19
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Zero Patients met criteria
- **Last updated:** 2021-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04411316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04411316, "Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04411316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*